Cellectis (CLLS) Short-term Investments (2013 - 2026)
Cellectis' Short-term Investments was $131.26 million in Q2 2026, down 5.1% from $138.34 million a year earlier and down 13.0% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Short-term Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Cellectis came in at $147.13 million, up 25.7% from FY2024.
- Short-term Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $117.06 million in FY2024 (+74.4%), $67.11 million in FY2023 (+748.7%), $7.91 million in FY2022 and $499,000 in FY2021 (-98.2%).
- The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q1 2025.
- Compared with a year earlier, Short-term Investments was higher in five of the last six quarters, with growth averaging 21.4%.
- The best year-over-year quarter for Short-term Investments over five years was Q1 2023 (growth of 831.3%); the worst was Q3 2021 (a decline of 99.0%).
- Per Business Quant data, CLLS's Short-term Investments in the three quarters before Q2 2026 was $150.82 million (Q1 2026), $147.13 million (Q4 2025) and $139.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Cellectis | 140.48 Mn | -612.92 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131.26 Mn |
| Mar 31, 2026 | 150.82 Mn |
| Dec 31, 2025 | 147.13 Mn |
| Sep 30, 2025 | 139.98 Mn |
| Jun 30, 2025 | 138.34 Mn |
| Mar 31, 2025 | 116.06 Mn |
| Dec 31, 2024 | 117.06 Mn |
| Sep 30, 2024 | 101.86 Mn |
| Jun 30, 2024 | 123.77 Mn |
| Mar 31, 2024 | 90.13 Mn |
| Dec 31, 2023 | -13.36 Mn |
| Sep 30, 2023 | 489,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | 126,000.00 |
| Sep 30, 2022 | 21.36 Mn |
| Jun 30, 2022 | 24.19 Mn |
| Mar 31, 2022 | 499,000.00 |
| Dec 31, 2021 | -143,000.00 |
| Sep 30, 2021 | 393,000.00 |
API Access
Cellectis Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();